These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4218943)

  • 21. In vitro studies of tobramycin, an aminoglycoside antibiotic.
    Dienstag J; Neu HC
    Antimicrob Agents Chemother; 1972 Jan; 1(1):41-5. PubMed ID: 4670427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative activity of tobramycin and gentamicin against Pseudomonas, Proteus and Providencia species.
    Ducan IB; Penner JL
    Can Med Assoc J; 1975 Jul; 113(1):29-31. PubMed ID: 807310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The inhibitory effect of sodium alginate on antibiotic activity against mucoid and non-mucoid strains of Pseudomonas aeruginosa.
    Baltimore RS; Cross AS; Dobek AS
    J Antimicrob Chemother; 1987 Dec; 20(6):815-23. PubMed ID: 2964429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gentamicin and tobramycin--an in vitro comparison using 1400 clinical isolates.
    Forgan-Smith WR; Andrew JH; McSweeney RJ
    Pathology; 1976 Jul; 8(3):195-9. PubMed ID: 826868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tobramycin: a review of its antibacterial and pharmacokinetic properties and therapeutic use.
    Brogden RN; Pinder RM; Sawyer PR; Speight TM; Avery GS
    Drugs; 1976; 12(3):166-200. PubMed ID: 789045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of netilmicin compared with those of gentamicin and tobramycin against enterobacteria and Pseudomonas aeruginosa.
    Chadwick P; Salmon S; Taylor B
    Antimicrob Agents Chemother; 1977 Sep; 12(3):301-7. PubMed ID: 410361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the susceptibility of 150 consecutive clinical isolates of Pseudomonas aeruginosa to tobramycin, gentamicin, colistin, carbenicillin, and five other antimicrobials.
    Lockwood WR; Lawson LA
    Antimicrob Agents Chemother; 1973 Sep; 4(3):281-4. PubMed ID: 4202342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of the aerosolized agents colistin and tobramycin and five intravenous agents against Pseudomonas aeruginosa isolated from cystic fibrosis patients in southwestern Germany.
    Schülin T
    J Antimicrob Chemother; 2002 Feb; 49(2):403-6. PubMed ID: 11815589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of gentamicin, tobramycin, polymyxin B, and colistimethate in mouse protection tests with Pseudomonas aeruginosa.
    Davis SD
    Antimicrob Agents Chemother; 1975 Jul; 8(1):50-3. PubMed ID: 169729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutant prevention concentrations of levofloxacin alone and in combination with azithromycin, ceftazidime, colistin (Polymyxin E), meropenem, piperacillin-tazobactam, and tobramycin against Pseudomonas aeruginosa.
    Zhanel GG; Mayer M; Laing N; Adam HJ
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2228-30. PubMed ID: 16723591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic activities of combinations of beta-lactams, fosfomycin, and tobramycin against Pseudomonas aeruginosa.
    Takahashi K; Kanno H
    Antimicrob Agents Chemother; 1984 Nov; 26(5):789-91. PubMed ID: 6440482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro bactericidal effectiveness of four aminoglycoside antibiotics.
    Hyams PJ; Simberkoff MS; Rahal JJ
    Antimicrob Agents Chemother; 1973 Jan; 3(1):87-94. PubMed ID: 4790579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative study of the antibacterial activity of a number of new antibiotics and their combinations in relation to Pseudomonas aeruginosa].
    Bekbergenov BM; Moroz AF; Rudzit EA; Stepanets TH
    Antibiotiki; 1979 May; 24(5):340-3. PubMed ID: 109038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Susceptibility of nonfermentative gram-negative bacilli to tobramycin.
    Uwaydah M; Taqi-Eddin AR
    J Infect Dis; 1976 Aug; 134 Suppl():S28-32. PubMed ID: 823278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibacterial activity of ticarcillin, tobramycin and gentamicin alone and in combination against Pseudomonas aeruginosa in vitro.
    Ullmann U
    Chemotherapy; 1977; 23(5):314-23. PubMed ID: 409590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative study of the antibacterial activity of aminoglycoside antibiotics and their combinations with carbenicillin against Pseudomonas aeruginosa].
    Iakushkina IV; Shapovalova SP; Malkova IV
    Antibiotiki; 1982 Aug; 27(8):601-7. PubMed ID: 6812489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Error rates associated with the use of recently proposed breakpoints for testing Pseudomonas aeruginosa versus gentamicin, tobramycin, and amikacin by the standardized disk agar diffusion test.
    Woolfrey BF; Fox JM; Quall CO; Lally RT
    Antimicrob Agents Chemother; 1983 Nov; 24(5):764-70. PubMed ID: 6419674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic bone cement for the treatment of Pseudomonas aeruginosa in joint arthroplasty: comparison of tobramycin and gentamicin-loaded cements.
    Scott CP; Higham PA
    J Biomed Mater Res B Appl Biomater; 2003 Feb; 64(2):94-8. PubMed ID: 12516083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laboratory findings of tobramycin and their relation to clinical response.
    McAllister TA; Tait SC
    J Infect Dis; 1976 Aug; 134 Suppl():S20-7. PubMed ID: 823277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inter- and intralaboratory variability in antibiotic susceptibility tests with Pseudomonas aeruginosa and Enterobacteriaceae.
    Barry AL; Schoenknecht FD; Norton R; O'Brien TF; Matsen JM; Thornsberry C; Thrupp LD; Markley E; Gavan TL
    J Infect Dis; 1976 Oct; 134(4):328-35. PubMed ID: 185302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.